Nixon Alan J, Dahlgren Linda A, Haupt Jennifer L, Yeager Amy E, Ward Daniel L
Comparative Orthopaedics Laboratory, Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853-6401, USA.
Am J Vet Res. 2008 Jul;69(7):928-37. doi: 10.2460/ajvr.69.7.928.
To assess the potential of adipose-derived nucleated cell (ADNC) fractions to improve tendon repair in horses with collagenase-induced tendinitis.
8 horses.
Collagenase was used to induce tendinitis in the superficial digital flexor tendon of 1 forelimb in each horse. Four horses were treated by injection of autogenous ADNC fractions, and 4 control horses were injected with PBS solution. Healing was compared by weekly ultrasonographic evaluation. Horses were euthanatized at 6 weeks. Gross and histologic evaluation of tendon structure, fiber alignment, and collagen typing were used to define tendon architecture. Biochemical and molecular analyses of collagen, DNA, and proteoglycan and gene expression of collagen type I and type III, decorin, cartilage oligomeric matrix protein (COMP), and insulin-like growth factor-I were performed.
Ultrasonography revealed no difference in rate or quality of repair between groups. Histologic evaluation revealed a significant improvement in tendon fiber architecture; reductions in vascularity, inflammatory cell infiltrate, and collagen type III formation; and improvements in tendon fiber density and alignment in ADNC-treated tendons. Repair sites did not differ in DNA, proteoglycan, or total collagen content. Gene expression of collagen type I and type III in treated and control tendons were similar. Gene expression of COMP was significantly increased in ADNC-injected tendons.
ADNC injection improved tendon organization in treated tendons. Although biochemical and molecular differences were less profound, tendons appeared architecturally improved after ADNC injection, which was corroborated by improved tendon COMP expression. Use of ADNC in horses with tendinitis appears warranted.
评估脂肪来源有核细胞(ADNC)组分改善胶原酶诱导性肌腱炎马匹肌腱修复的潜力。
8匹马。
在每匹马的1个前肢的指浅屈肌腱中使用胶原酶诱导肌腱炎。4匹马接受自体ADNC组分注射治疗,4匹对照马注射磷酸盐缓冲液(PBS)溶液。通过每周的超声评估比较愈合情况。6周时对马匹实施安乐死。采用对肌腱结构、纤维排列和胶原分型的大体和组织学评估来确定肌腱结构。对胶原、DNA、蛋白聚糖进行生化和分子分析,并检测I型和III型胶原、核心蛋白聚糖、软骨寡聚基质蛋白(COMP)和胰岛素样生长因子-I的基因表达。
超声检查显示两组之间在修复速度或质量上无差异。组织学评估显示,ADNC治疗的肌腱在肌腱纤维结构方面有显著改善;血管形成、炎性细胞浸润和III型胶原形成减少;肌腱纤维密度和排列有所改善。修复部位在DNA、蛋白聚糖或总胶原含量方面无差异。治疗组和对照组肌腱中I型和III型胶原的基因表达相似。注射ADNC的肌腱中COMP的基因表达显著增加。
ADNC注射改善了治疗肌腱的组织结构。尽管生化和分子差异不那么明显,但ADNC注射后肌腱在结构上似乎有所改善,这一点通过肌腱COMP表达的改善得到了证实。在患有肌腱炎的马匹中使用ADNC似乎是有必要的。